cancerTiming statistics

info info

Citations per year

Number of citations per year for the bioinformatics software tool cancerTiming
info

Tool usage distribution map

info info

Associated diseases

info

Popular tool citations

chevron_left Tumor purity and heterogeneity estimation chevron_right
Want to access the full stats & trends on this tool?

cancerTiming specifications

Information


Unique identifier OMICS_09039
Name cancerTiming
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux, Mac OS, Windows
Programming languages R
License GNU General Public License version 2.0
Computer skills Advanced
Version 3.1.8
Stability Stable
Requirements
stats, gplots, graphics, IRanges, GenomicRanges, utils, S4Vectors, grDevices, R(≥2.11.0), LearnBayes
Maintained Yes

Versioning


No version available

Documentation


Maintainer


  • person_outline Elizabeth Purdom

Publication for cancerTiming

cancerTiming citation

library_books

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

2015
PMCID: 5008168
PMID: 25711488
DOI: 10.1111/bju.13101

[…] DRESymptoms suggest BOO secondary to BPE , , Patient concern in relation to prostate cancer Abnormal prostate on DRESymptoms suggest BOO secondary to BPE , , Patient concern in relation to prostate cancerTiming:PSA testing should be postponed for: 6 weeks after treatment for UTI1 week after DRE48 hours after vigorous exercise or sexual activity6 weeks after prostate biopsy2 weeks after flu‐like […]


Want to access the full list of citations?
cancerTiming institution(s)
Department of Statistics, University of California, Berkeley, Evans Hall Berkeley, CA, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA; Department of Dermatology, University of California, San Francisco, CA, USA
cancerTiming funding source(s)
National Institute of Health TCGA grant (U24 CA143799); the Anna Fuller fund; the Dermatology Foundation; the American Skin Association; and National Science Foundation grants (DMS-0636667, DMS-1026441)

cancerTiming reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review cancerTiming